Clinical Research Directory
Browse clinical research sites, groups, and studies.
EucaLimus Post-Market Registry
Sponsor: OrbusNeich
Summary
To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the Eucalimus sirolimus eluting PTCA stent when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Eucalimus PTCA stent in routine clinical practice.
Official title: Coronary Angioplasty With Sirolimus Drug-coated Stent System to Treat Patients With Symptomatic Ischemic Coronary Heart Disease: a PMCF Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
251
Start Date
2025-03-14
Completion Date
2029-01
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
EucaLimus coronary stent system
The EucaLimus coronary stent system is a drug-coated coronary stent system, indicated for use in patients with symptomatic ischaemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries.
Locations (10)
Krajska nemocnice Liberec
Liberec, Czechia
Motol University Hospital
Prague, Czechia
Institut Jantung Negara
Kuala Lumpur, Malaysia
Bellvitge University Hospital
L'Hospitalet de Llobregat, Catalonia, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Universitario Lucus Augusti
Lugo, Spain
Complejo Hospitalario Universitario de Canarias
San Cristóbal de La Laguna, Spain
Hospital Universitario Joan XXIII
Tarragona, Spain